Skip to main content

Advertisement

Table 1 Clinical and metabolic parameters of MetS, Obese and control groups

From: Serum prolidase activity is associated with non-diabetic metabolic syndrome

  MetS (n = 34, 31M and 3F) Obese (n = 30, 28M and 2F) Control (n = 23, 20M and 3F)
Age (years) 35.18 ± 6.8 33.67 ± 7.9 32.39 ± 4.7
Body weight (kg) 97.27 ± 12.6b,f 92.07 ± 19.2c 60.30 ± 10.3
BMI (kg/m2) 38.91 ± 5.5b 36.59 ± 5.2c 22.93 ± 3.4
Waist-C (cm) 106.85 ± 10.3b,f 99.73 ± 13.2c 75.52 ± 8.1
SBP (mmHg) 136.77 ± 12.0a,b 118.67 ± 13.1c 105.65 ± 7.7
DBP (mmHg)* 90(70–110)a,b 80(70–100)c 60(50–80)
TC (mg/dl) 194.39 ± 35.6e 181.66 ± 24.2 168.13 ± 24.7
HDL (mg/dl) 44.39 ± 13.3b 42.14 ± 9.9 55.65 ± 5.2
TG (mg/dl) 174.91 ± 72.9a,b 100.07 ± 35.3 73.44 ± 30.6
LDL (mg/dl) 113.68 ± 37.4 117.76 ± 23.4h 97.80 ± 21.9
TOS (mmol H2O2 Equiv./l) 13.94 ± 2.19e,f 12.74 ± 2.1 13.05 ± 2.3
TAS (mmol Trolox Equiv./l) 0.95 ± 0.1a,b 1.10 ± 0.1h 1.16 ± 0.1
OSI (arbitrary unit) 14.67 ± 2.2a,b 11.48 ± 2.3 10.65 ± 2.4
FPG (mg/dl) 102.88 ± 13.3b 97.94 ± 7.4h 90.87 ± 9.8
Prolidase 708.93 ± 10.4b,f 703.17 ± 8.1h 696.69 ± 11.5
  1. BMI, body mass index; DBP, diastolic blood pressure; FPG, fasting plasma glucose; HDL, high-density lipoprotein; LDL, low-density lipoprotein; MetS, metabolic syndrome; OSI, oxidative stress index SBP, systolic blood pressure; TAS, total antioxidant status; TC, total cholesterol;TG, triglyceride; TOS, total oxidative status; Waist-C, waist circumference. *Data in which non-parametric tests were used and expressed as median (range). P < 0.001: aMetS versus obese; bMetS versus control; cobese versus control. P < 0.01: dMetS versus obese; eMetS versus control. P < 0.05: fMetS versus obese; gMetS versus control; hobese versus control.